-
Notifications
You must be signed in to change notification settings - Fork 81
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Vaccines outline #828
Vaccines outline #828
Conversation
AppVeyor build 1.0.3052 for commit ad12a0a is now complete. Found 8 potential spelling error(s). Preview:content/20.pharmaceuticals.md:818:AstraZenecacontent/20.pharmaceuticals.md:822:Janssen’s content/20.pharmaceuticals.md:828:CoronaVac content/20.pharmaceuticals.md:828:SinoVac's content/20.pharmaceuticals.md:831:Sinopharm content/20.pharmaceuticals.md:837:Novavax content/20.pharmaceuticals.md:837:NVX content/21.nutraceuticals.md:6:repurposed... |
Hey @rando2, my thoughts would be that it probably makes sense to split the vaccine section up into its own manuscript if the therapeutics paper is miles over the word limit. Ultimately, @ajlee21, @nilswellhausen etc. have contributed the most so go with their thoughts. If you do split, there is plenty updates on each of those vaccines to include. I think maybe the discussion should also briefly address the current state of vaccine distribution e.g. Moderna & Pfizer leading the way in most countries etc. mentioning the logistical issues of transport and distribution currently exposed. That would round the outline off nicely. I can help out towards the end of the week. |
I agree that it probably makes sense to split vaccines since that topic has enough volume to be its own manuscript. That way we can focus on updating the vaccine section separately and go into the data more in-depth rather than trying to squeeze this in here. |
Yes I very much agree with the above comments. Will start trying to take a look at the vaccine sections later this week |
Thank you so much @RLordan! |
[ci skip] This build is based on 61b73a3. This commit was created by the following CI build and job: https://github.com/greenelab/covid19-review/commit/61b73a37940b18f240bdf0c5effe95e60e847e6e/checks https://github.com/greenelab/covid19-review/runs/530944760
[ci skip] This build is based on 61b73a3. This commit was created by the following CI build and job: https://github.com/greenelab/covid19-review/commit/61b73a37940b18f240bdf0c5effe95e60e847e6e/checks https://github.com/greenelab/covid19-review/runs/530944760
Description of the proposed additions or changes
This is a suggestion for the sections of info that we probably want to add about the vaccines (as well as some possible tweaks to the vaccine figure).
However, I'm starting to think we might just want to split this section out and submit the therapeutics paper separately, since that one is basically ready to go and this needs some additions still -- plus we are already like 8000 words over the word limit 😓
Related issues
#738
Suggested reviewers (optional)
@ajlee21 @nilswellhausen I would love to get your feedback since you have both been very involved with what's been done!
@likhithakolla and @cgreene as well, since you had written a lot of the mRNA vaccine section
And @RLordan you have been giving very helpful feedback on #740 and #741 as well, so just in case you have any thoughts!
Checklist